Global Drug Safety and Pharmacovigilance (PV) Software Market Growth (Status and Outlook) 2026-2032
The global Drug Safety and Pharmacovigilance (PV) Software market size is predicted to grow from US$ 275 million in 2025 to US$ 398 million in 2032; it is expected to grow at a CAGR of 5.4% from 2026 to 2032.
Drug Safety and Pharmacovigilance (PV) Software is an automated, information-based tool used by pharmaceutical companies, healthcare institutions, and regulatory authorities to monitor, assess, and prevent adverse drug reactions (ADRs) and safety risks throughout the entire drug lifecycle. It ensures drug compliance, aims to protect public health, improve patient safety, and meet the legal obligations of marketing authorization holders (MAHs).
As global drug regulatory agencies (such as the FDA, EMA, and NMPA) continue to tighten post-marketing regulatory requirements, the traditional manual review-based Individual Case Safety Report (ICSR) processing model can no longer cope with the explosive growth of massive amounts of data. Current leading opinions emphasize that by 2026, the core competitiveness of the market will focus on the full-stack integration capability of AI, that is, whether software can automate the entire process from scanning original documents and automatically sorting cases to providing scientific writing suggestions through large language models and natural language processing. This transformation makes pharmacovigilance software no longer just a database tool, but an indispensable 'risk warning center' in pharmaceutical companies' R&D decision-making.
LPI (LP Information)' newest research report, the ?Drug Safety and Pharmacovigilance (PV) Software Industry Forecast? looks at past sales and reviews total world Drug Safety and Pharmacovigilance (PV) Software sales in 2025, providing a comprehensive analysis by region and market sector of projected Drug Safety and Pharmacovigilance (PV) Software sales for 2026 through 2032. With Drug Safety and Pharmacovigilance (PV) Software sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drug Safety and Pharmacovigilance (PV) Software industry.
This Insight Report provides a comprehensive analysis of the global Drug Safety and Pharmacovigilance (PV) Software landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Drug Safety and Pharmacovigilance (PV) Software portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Drug Safety and Pharmacovigilance (PV) Software market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drug Safety and Pharmacovigilance (PV) Software and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drug Safety and Pharmacovigilance (PV) Software.
This report presents a comprehensive overview, market shares, and growth opportunities of Drug Safety and Pharmacovigilance (PV) Software market by product type, application, key players and key regions and countries.
Segmentation by Type:
Drug Safety and Pharmacovigilance (PV) Software is an automated, information-based tool used by pharmaceutical companies, healthcare institutions, and regulatory authorities to monitor, assess, and prevent adverse drug reactions (ADRs) and safety risks throughout the entire drug lifecycle. It ensures drug compliance, aims to protect public health, improve patient safety, and meet the legal obligations of marketing authorization holders (MAHs).
As global drug regulatory agencies (such as the FDA, EMA, and NMPA) continue to tighten post-marketing regulatory requirements, the traditional manual review-based Individual Case Safety Report (ICSR) processing model can no longer cope with the explosive growth of massive amounts of data. Current leading opinions emphasize that by 2026, the core competitiveness of the market will focus on the full-stack integration capability of AI, that is, whether software can automate the entire process from scanning original documents and automatically sorting cases to providing scientific writing suggestions through large language models and natural language processing. This transformation makes pharmacovigilance software no longer just a database tool, but an indispensable 'risk warning center' in pharmaceutical companies' R&D decision-making.
LPI (LP Information)' newest research report, the ?Drug Safety and Pharmacovigilance (PV) Software Industry Forecast? looks at past sales and reviews total world Drug Safety and Pharmacovigilance (PV) Software sales in 2025, providing a comprehensive analysis by region and market sector of projected Drug Safety and Pharmacovigilance (PV) Software sales for 2026 through 2032. With Drug Safety and Pharmacovigilance (PV) Software sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drug Safety and Pharmacovigilance (PV) Software industry.
This Insight Report provides a comprehensive analysis of the global Drug Safety and Pharmacovigilance (PV) Software landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Drug Safety and Pharmacovigilance (PV) Software portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Drug Safety and Pharmacovigilance (PV) Software market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drug Safety and Pharmacovigilance (PV) Software and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drug Safety and Pharmacovigilance (PV) Software.
This report presents a comprehensive overview, market shares, and growth opportunities of Drug Safety and Pharmacovigilance (PV) Software market by product type, application, key players and key regions and countries.
Segmentation by Type:
- On-Premises
- Cloud-Based
- Pre-market
- Post-market
- Security Database
- Signal Detection
- Compliance Report
- Other
- Pharma and Biotech Companies
- Contract Research Organizations (CROs)
- Business Process Outsourcing (BPO) Firms
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Oracle
- Veeva Systems
- ArisGlobal
- IQVIA
- EXTEDO
- RxLogix
- Ennov
- Uppsala Monitoring Centre
- Medidata
- Clarivate
- AB Cube
- Cloudbyz
- Cognizant Technology
- Taimei Technology
- eMedyun
- Bioknow
- Singedi Health
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Drug Safety and Pharmacovigilance (PV) Software Market Size (2021-2032)
2.1.2 Drug Safety and Pharmacovigilance (PV) Software Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Drug Safety and Pharmacovigilance (PV) Software by Country/Region (2021, 2025 & 2032)
2.2 Drug Safety and Pharmacovigilance (PV) Software Segment by Type
2.2.1 On-Premises
2.2.2 Cloud-Based
2.2.3 Drug Safety and Pharmacovigilance (PV) Software Market Size by Type
2.2.3.1 Drug Safety and Pharmacovigilance (PV) Software Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Type (2021-2026)
2.3 Drug Safety and Pharmacovigilance (PV) Software Segment by Data Range
2.3.1 Pre-market
2.3.2 Post-market
2.3.3 Drug Safety and Pharmacovigilance (PV) Software Market Size by Data Range
2.3.3.1 Drug Safety and Pharmacovigilance (PV) Software Market Size CAGR by Data Range (2021 VS 2025 VS 2032)
2.3.3.2 Global Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Data Range (2021-2026)
2.4 Drug Safety and Pharmacovigilance (PV) Software Segment by Functional Modules
2.4.1 Security Database
2.4.2 Signal Detection
2.4.3 Compliance Report
2.4.4 Other
2.4.5 Drug Safety and Pharmacovigilance (PV) Software Market Size by Functional Modules
2.4.5.1 Drug Safety and Pharmacovigilance (PV) Software Market Size CAGR by Functional Modules (2021 VS 2025 VS 2032)
2.4.5.2 Global Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Functional Modules (2021-2026)
2.5 Drug Safety and Pharmacovigilance (PV) Software Segment by Application
2.5.1 Pharma and Biotech Companies
2.5.2 Contract Research Organizations (CROs)
2.5.3 Business Process Outsourcing (BPO) Firms
2.5.4 Other
2.5.5 Drug Safety and Pharmacovigilance (PV) Software Market Size by Application
2.5.5.1 Drug Safety and Pharmacovigilance (PV) Software Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.5.2 Global Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Application (2021-2026)
3 DRUG SAFETY AND PHARMACOVIGILANCE (PV) SOFTWARE MARKET SIZE BY PLAYER
3.1 Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Player
3.1.1 Global Drug Safety and Pharmacovigilance (PV) Software Revenue by Player (2021-2026)
3.1.2 Global Drug Safety and Pharmacovigilance (PV) Software Revenue Market Share by Player (2021-2026)
3.2 Global Drug Safety and Pharmacovigilance (PV) Software Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 DRUG SAFETY AND PHARMACOVIGILANCE (PV) SOFTWARE BY REGION
4.1 Drug Safety and Pharmacovigilance (PV) Software Market Size by Region (2021-2026)
4.2 Global Drug Safety and Pharmacovigilance (PV) Software Annual Revenue by Country/Region (2021-2026)
4.3 Americas Drug Safety and Pharmacovigilance (PV) Software Market Size Growth (2021-2026)
4.4 APAC Drug Safety and Pharmacovigilance (PV) Software Market Size Growth (2021-2026)
4.5 Europe Drug Safety and Pharmacovigilance (PV) Software Market Size Growth (2021-2026)
4.6 Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Drug Safety and Pharmacovigilance (PV) Software Market Size by Country (2021-2026)
5.2 Americas Drug Safety and Pharmacovigilance (PV) Software Market Size by Type (2021-2026)
5.3 Americas Drug Safety and Pharmacovigilance (PV) Software Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drug Safety and Pharmacovigilance (PV) Software Market Size by Region (2021-2026)
6.2 APAC Drug Safety and Pharmacovigilance (PV) Software Market Size by Type (2021-2026)
6.3 APAC Drug Safety and Pharmacovigilance (PV) Software Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Drug Safety and Pharmacovigilance (PV) Software Market Size by Country (2021-2026)
7.2 Europe Drug Safety and Pharmacovigilance (PV) Software Market Size by Type (2021-2026)
7.3 Europe Drug Safety and Pharmacovigilance (PV) Software Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software by Region (2021-2026)
8.2 Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Size by Type (2021-2026)
8.3 Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL DRUG SAFETY AND PHARMACOVIGILANCE (PV) SOFTWARE MARKET FORECAST
10.1 Global Drug Safety and Pharmacovigilance (PV) Software Forecast by Region (2027-2032)
10.1.1 Global Drug Safety and Pharmacovigilance (PV) Software Forecast by Region (2027-2032)
10.1.2 Americas Drug Safety and Pharmacovigilance (PV) Software Forecast
10.1.3 APAC Drug Safety and Pharmacovigilance (PV) Software Forecast
10.1.4 Europe Drug Safety and Pharmacovigilance (PV) Software Forecast
10.1.5 Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Forecast
10.2 Americas Drug Safety and Pharmacovigilance (PV) Software Forecast by Country (2027-2032)
10.2.1 United States Market Drug Safety and Pharmacovigilance (PV) Software Forecast
10.2.2 Canada Market Drug Safety and Pharmacovigilance (PV) Software Forecast
10.2.3 Mexico Market Drug Safety and Pharmacovigilance (PV) Software Forecast
10.2.4 Brazil Market Drug Safety and Pharmacovigilance (PV) Software Forecast
10.3 APAC Drug Safety and Pharmacovigilance (PV) Software Forecast by Region (2027-2032)
10.3.1 China Drug Safety and Pharmacovigilance (PV) Software Market Forecast
10.3.2 Japan Market Drug Safety and Pharmacovigilance (PV) Software Forecast
10.3.3 Korea Market Drug Safety and Pharmacovigilance (PV) Software Forecast
10.3.4 Southeast Asia Market Drug Safety and Pharmacovigilance (PV) Software Forecast
10.3.5 India Market Drug Safety and Pharmacovigilance (PV) Software Forecast
10.3.6 Australia Market Drug Safety and Pharmacovigilance (PV) Software Forecast
10.4 Europe Drug Safety and Pharmacovigilance (PV) Software Forecast by Country (2027-2032)
10.4.1 Germany Market Drug Safety and Pharmacovigilance (PV) Software Forecast
10.4.2 France Market Drug Safety and Pharmacovigilance (PV) Software Forecast
10.4.3 UK Market Drug Safety and Pharmacovigilance (PV) Software Forecast
10.4.4 Italy Market Drug Safety and Pharmacovigilance (PV) Software Forecast
10.4.5 Russia Market Drug Safety and Pharmacovigilance (PV) Software Forecast
10.5 Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Forecast by Region (2027-2032)
10.5.1 Egypt Market Drug Safety and Pharmacovigilance (PV) Software Forecast
10.5.2 South Africa Market Drug Safety and Pharmacovigilance (PV) Software Forecast
10.5.3 Israel Market Drug Safety and Pharmacovigilance (PV) Software Forecast
10.5.4 Turkey Market Drug Safety and Pharmacovigilance (PV) Software Forecast
10.6 Global Drug Safety and Pharmacovigilance (PV) Software Forecast by Type (2027-2032)
10.7 Global Drug Safety and Pharmacovigilance (PV) Software Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Drug Safety and Pharmacovigilance (PV) Software Forecast
11 KEY PLAYERS ANALYSIS
11.1 Oracle
11.1.1 Oracle Company Information
11.1.2 Oracle Drug Safety and Pharmacovigilance (PV) Software Product Offered
11.1.3 Oracle Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Oracle Main Business Overview
11.1.5 Oracle Latest Developments
11.2 Veeva Systems
11.2.1 Veeva Systems Company Information
11.2.2 Veeva Systems Drug Safety and Pharmacovigilance (PV) Software Product Offered
11.2.3 Veeva Systems Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Veeva Systems Main Business Overview
11.2.5 Veeva Systems Latest Developments
11.3 ArisGlobal
11.3.1 ArisGlobal Company Information
11.3.2 ArisGlobal Drug Safety and Pharmacovigilance (PV) Software Product Offered
11.3.3 ArisGlobal Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 ArisGlobal Main Business Overview
11.3.5 ArisGlobal Latest Developments
11.4 IQVIA
11.4.1 IQVIA Company Information
11.4.2 IQVIA Drug Safety and Pharmacovigilance (PV) Software Product Offered
11.4.3 IQVIA Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 IQVIA Main Business Overview
11.4.5 IQVIA Latest Developments
11.5 EXTEDO
11.5.1 EXTEDO Company Information
11.5.2 EXTEDO Drug Safety and Pharmacovigilance (PV) Software Product Offered
11.5.3 EXTEDO Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 EXTEDO Main Business Overview
11.5.5 EXTEDO Latest Developments
11.6 RxLogix
11.6.1 RxLogix Company Information
11.6.2 RxLogix Drug Safety and Pharmacovigilance (PV) Software Product Offered
11.6.3 RxLogix Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 RxLogix Main Business Overview
11.6.5 RxLogix Latest Developments
11.7 Ennov
11.7.1 Ennov Company Information
11.7.2 Ennov Drug Safety and Pharmacovigilance (PV) Software Product Offered
11.7.3 Ennov Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Ennov Main Business Overview
11.7.5 Ennov Latest Developments
11.8 Uppsala Monitoring Centre
11.8.1 Uppsala Monitoring Centre Company Information
11.8.2 Uppsala Monitoring Centre Drug Safety and Pharmacovigilance (PV) Software Product Offered
11.8.3 Uppsala Monitoring Centre Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Uppsala Monitoring Centre Main Business Overview
11.8.5 Uppsala Monitoring Centre Latest Developments
11.9 Medidata
11.9.1 Medidata Company Information
11.9.2 Medidata Drug Safety and Pharmacovigilance (PV) Software Product Offered
11.9.3 Medidata Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Medidata Main Business Overview
11.9.5 Medidata Latest Developments
11.10 Clarivate
11.10.1 Clarivate Company Information
11.10.2 Clarivate Drug Safety and Pharmacovigilance (PV) Software Product Offered
11.10.3 Clarivate Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Clarivate Main Business Overview
11.10.5 Clarivate Latest Developments
11.11 AB Cube
11.11.1 AB Cube Company Information
11.11.2 AB Cube Drug Safety and Pharmacovigilance (PV) Software Product Offered
11.11.3 AB Cube Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 AB Cube Main Business Overview
11.11.5 AB Cube Latest Developments
11.12 Cloudbyz
11.12.1 Cloudbyz Company Information
11.12.2 Cloudbyz Drug Safety and Pharmacovigilance (PV) Software Product Offered
11.12.3 Cloudbyz Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Cloudbyz Main Business Overview
11.12.5 Cloudbyz Latest Developments
11.13 Cognizant Technology
11.13.1 Cognizant Technology Company Information
11.13.2 Cognizant Technology Drug Safety and Pharmacovigilance (PV) Software Product Offered
11.13.3 Cognizant Technology Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Cognizant Technology Main Business Overview
11.13.5 Cognizant Technology Latest Developments
11.14 Taimei Technology
11.14.1 Taimei Technology Company Information
11.14.2 Taimei Technology Drug Safety and Pharmacovigilance (PV) Software Product Offered
11.14.3 Taimei Technology Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Taimei Technology Main Business Overview
11.14.5 Taimei Technology Latest Developments
11.15 eMedyun
11.15.1 eMedyun Company Information
11.15.2 eMedyun Drug Safety and Pharmacovigilance (PV) Software Product Offered
11.15.3 eMedyun Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 eMedyun Main Business Overview
11.15.5 eMedyun Latest Developments
11.16 Bioknow
11.16.1 Bioknow Company Information
11.16.2 Bioknow Drug Safety and Pharmacovigilance (PV) Software Product Offered
11.16.3 Bioknow Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Bioknow Main Business Overview
11.16.5 Bioknow Latest Developments
11.17 Singedi Health
11.17.1 Singedi Health Company Information
11.17.2 Singedi Health Drug Safety and Pharmacovigilance (PV) Software Product Offered
11.17.3 Singedi Health Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 Singedi Health Main Business Overview
11.17.5 Singedi Health Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Drug Safety and Pharmacovigilance (PV) Software Market Size (2021-2032)
2.1.2 Drug Safety and Pharmacovigilance (PV) Software Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Drug Safety and Pharmacovigilance (PV) Software by Country/Region (2021, 2025 & 2032)
2.2 Drug Safety and Pharmacovigilance (PV) Software Segment by Type
2.2.1 On-Premises
2.2.2 Cloud-Based
2.2.3 Drug Safety and Pharmacovigilance (PV) Software Market Size by Type
2.2.3.1 Drug Safety and Pharmacovigilance (PV) Software Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Type (2021-2026)
2.3 Drug Safety and Pharmacovigilance (PV) Software Segment by Data Range
2.3.1 Pre-market
2.3.2 Post-market
2.3.3 Drug Safety and Pharmacovigilance (PV) Software Market Size by Data Range
2.3.3.1 Drug Safety and Pharmacovigilance (PV) Software Market Size CAGR by Data Range (2021 VS 2025 VS 2032)
2.3.3.2 Global Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Data Range (2021-2026)
2.4 Drug Safety and Pharmacovigilance (PV) Software Segment by Functional Modules
2.4.1 Security Database
2.4.2 Signal Detection
2.4.3 Compliance Report
2.4.4 Other
2.4.5 Drug Safety and Pharmacovigilance (PV) Software Market Size by Functional Modules
2.4.5.1 Drug Safety and Pharmacovigilance (PV) Software Market Size CAGR by Functional Modules (2021 VS 2025 VS 2032)
2.4.5.2 Global Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Functional Modules (2021-2026)
2.5 Drug Safety and Pharmacovigilance (PV) Software Segment by Application
2.5.1 Pharma and Biotech Companies
2.5.2 Contract Research Organizations (CROs)
2.5.3 Business Process Outsourcing (BPO) Firms
2.5.4 Other
2.5.5 Drug Safety and Pharmacovigilance (PV) Software Market Size by Application
2.5.5.1 Drug Safety and Pharmacovigilance (PV) Software Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.5.2 Global Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Application (2021-2026)
3 DRUG SAFETY AND PHARMACOVIGILANCE (PV) SOFTWARE MARKET SIZE BY PLAYER
3.1 Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Player
3.1.1 Global Drug Safety and Pharmacovigilance (PV) Software Revenue by Player (2021-2026)
3.1.2 Global Drug Safety and Pharmacovigilance (PV) Software Revenue Market Share by Player (2021-2026)
3.2 Global Drug Safety and Pharmacovigilance (PV) Software Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 DRUG SAFETY AND PHARMACOVIGILANCE (PV) SOFTWARE BY REGION
4.1 Drug Safety and Pharmacovigilance (PV) Software Market Size by Region (2021-2026)
4.2 Global Drug Safety and Pharmacovigilance (PV) Software Annual Revenue by Country/Region (2021-2026)
4.3 Americas Drug Safety and Pharmacovigilance (PV) Software Market Size Growth (2021-2026)
4.4 APAC Drug Safety and Pharmacovigilance (PV) Software Market Size Growth (2021-2026)
4.5 Europe Drug Safety and Pharmacovigilance (PV) Software Market Size Growth (2021-2026)
4.6 Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Drug Safety and Pharmacovigilance (PV) Software Market Size by Country (2021-2026)
5.2 Americas Drug Safety and Pharmacovigilance (PV) Software Market Size by Type (2021-2026)
5.3 Americas Drug Safety and Pharmacovigilance (PV) Software Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drug Safety and Pharmacovigilance (PV) Software Market Size by Region (2021-2026)
6.2 APAC Drug Safety and Pharmacovigilance (PV) Software Market Size by Type (2021-2026)
6.3 APAC Drug Safety and Pharmacovigilance (PV) Software Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Drug Safety and Pharmacovigilance (PV) Software Market Size by Country (2021-2026)
7.2 Europe Drug Safety and Pharmacovigilance (PV) Software Market Size by Type (2021-2026)
7.3 Europe Drug Safety and Pharmacovigilance (PV) Software Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software by Region (2021-2026)
8.2 Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Size by Type (2021-2026)
8.3 Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL DRUG SAFETY AND PHARMACOVIGILANCE (PV) SOFTWARE MARKET FORECAST
10.1 Global Drug Safety and Pharmacovigilance (PV) Software Forecast by Region (2027-2032)
10.1.1 Global Drug Safety and Pharmacovigilance (PV) Software Forecast by Region (2027-2032)
10.1.2 Americas Drug Safety and Pharmacovigilance (PV) Software Forecast
10.1.3 APAC Drug Safety and Pharmacovigilance (PV) Software Forecast
10.1.4 Europe Drug Safety and Pharmacovigilance (PV) Software Forecast
10.1.5 Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Forecast
10.2 Americas Drug Safety and Pharmacovigilance (PV) Software Forecast by Country (2027-2032)
10.2.1 United States Market Drug Safety and Pharmacovigilance (PV) Software Forecast
10.2.2 Canada Market Drug Safety and Pharmacovigilance (PV) Software Forecast
10.2.3 Mexico Market Drug Safety and Pharmacovigilance (PV) Software Forecast
10.2.4 Brazil Market Drug Safety and Pharmacovigilance (PV) Software Forecast
10.3 APAC Drug Safety and Pharmacovigilance (PV) Software Forecast by Region (2027-2032)
10.3.1 China Drug Safety and Pharmacovigilance (PV) Software Market Forecast
10.3.2 Japan Market Drug Safety and Pharmacovigilance (PV) Software Forecast
10.3.3 Korea Market Drug Safety and Pharmacovigilance (PV) Software Forecast
10.3.4 Southeast Asia Market Drug Safety and Pharmacovigilance (PV) Software Forecast
10.3.5 India Market Drug Safety and Pharmacovigilance (PV) Software Forecast
10.3.6 Australia Market Drug Safety and Pharmacovigilance (PV) Software Forecast
10.4 Europe Drug Safety and Pharmacovigilance (PV) Software Forecast by Country (2027-2032)
10.4.1 Germany Market Drug Safety and Pharmacovigilance (PV) Software Forecast
10.4.2 France Market Drug Safety and Pharmacovigilance (PV) Software Forecast
10.4.3 UK Market Drug Safety and Pharmacovigilance (PV) Software Forecast
10.4.4 Italy Market Drug Safety and Pharmacovigilance (PV) Software Forecast
10.4.5 Russia Market Drug Safety and Pharmacovigilance (PV) Software Forecast
10.5 Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Forecast by Region (2027-2032)
10.5.1 Egypt Market Drug Safety and Pharmacovigilance (PV) Software Forecast
10.5.2 South Africa Market Drug Safety and Pharmacovigilance (PV) Software Forecast
10.5.3 Israel Market Drug Safety and Pharmacovigilance (PV) Software Forecast
10.5.4 Turkey Market Drug Safety and Pharmacovigilance (PV) Software Forecast
10.6 Global Drug Safety and Pharmacovigilance (PV) Software Forecast by Type (2027-2032)
10.7 Global Drug Safety and Pharmacovigilance (PV) Software Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Drug Safety and Pharmacovigilance (PV) Software Forecast
11 KEY PLAYERS ANALYSIS
11.1 Oracle
11.1.1 Oracle Company Information
11.1.2 Oracle Drug Safety and Pharmacovigilance (PV) Software Product Offered
11.1.3 Oracle Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Oracle Main Business Overview
11.1.5 Oracle Latest Developments
11.2 Veeva Systems
11.2.1 Veeva Systems Company Information
11.2.2 Veeva Systems Drug Safety and Pharmacovigilance (PV) Software Product Offered
11.2.3 Veeva Systems Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Veeva Systems Main Business Overview
11.2.5 Veeva Systems Latest Developments
11.3 ArisGlobal
11.3.1 ArisGlobal Company Information
11.3.2 ArisGlobal Drug Safety and Pharmacovigilance (PV) Software Product Offered
11.3.3 ArisGlobal Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 ArisGlobal Main Business Overview
11.3.5 ArisGlobal Latest Developments
11.4 IQVIA
11.4.1 IQVIA Company Information
11.4.2 IQVIA Drug Safety and Pharmacovigilance (PV) Software Product Offered
11.4.3 IQVIA Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 IQVIA Main Business Overview
11.4.5 IQVIA Latest Developments
11.5 EXTEDO
11.5.1 EXTEDO Company Information
11.5.2 EXTEDO Drug Safety and Pharmacovigilance (PV) Software Product Offered
11.5.3 EXTEDO Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 EXTEDO Main Business Overview
11.5.5 EXTEDO Latest Developments
11.6 RxLogix
11.6.1 RxLogix Company Information
11.6.2 RxLogix Drug Safety and Pharmacovigilance (PV) Software Product Offered
11.6.3 RxLogix Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 RxLogix Main Business Overview
11.6.5 RxLogix Latest Developments
11.7 Ennov
11.7.1 Ennov Company Information
11.7.2 Ennov Drug Safety and Pharmacovigilance (PV) Software Product Offered
11.7.3 Ennov Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Ennov Main Business Overview
11.7.5 Ennov Latest Developments
11.8 Uppsala Monitoring Centre
11.8.1 Uppsala Monitoring Centre Company Information
11.8.2 Uppsala Monitoring Centre Drug Safety and Pharmacovigilance (PV) Software Product Offered
11.8.3 Uppsala Monitoring Centre Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Uppsala Monitoring Centre Main Business Overview
11.8.5 Uppsala Monitoring Centre Latest Developments
11.9 Medidata
11.9.1 Medidata Company Information
11.9.2 Medidata Drug Safety and Pharmacovigilance (PV) Software Product Offered
11.9.3 Medidata Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Medidata Main Business Overview
11.9.5 Medidata Latest Developments
11.10 Clarivate
11.10.1 Clarivate Company Information
11.10.2 Clarivate Drug Safety and Pharmacovigilance (PV) Software Product Offered
11.10.3 Clarivate Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Clarivate Main Business Overview
11.10.5 Clarivate Latest Developments
11.11 AB Cube
11.11.1 AB Cube Company Information
11.11.2 AB Cube Drug Safety and Pharmacovigilance (PV) Software Product Offered
11.11.3 AB Cube Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 AB Cube Main Business Overview
11.11.5 AB Cube Latest Developments
11.12 Cloudbyz
11.12.1 Cloudbyz Company Information
11.12.2 Cloudbyz Drug Safety and Pharmacovigilance (PV) Software Product Offered
11.12.3 Cloudbyz Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Cloudbyz Main Business Overview
11.12.5 Cloudbyz Latest Developments
11.13 Cognizant Technology
11.13.1 Cognizant Technology Company Information
11.13.2 Cognizant Technology Drug Safety and Pharmacovigilance (PV) Software Product Offered
11.13.3 Cognizant Technology Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Cognizant Technology Main Business Overview
11.13.5 Cognizant Technology Latest Developments
11.14 Taimei Technology
11.14.1 Taimei Technology Company Information
11.14.2 Taimei Technology Drug Safety and Pharmacovigilance (PV) Software Product Offered
11.14.3 Taimei Technology Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Taimei Technology Main Business Overview
11.14.5 Taimei Technology Latest Developments
11.15 eMedyun
11.15.1 eMedyun Company Information
11.15.2 eMedyun Drug Safety and Pharmacovigilance (PV) Software Product Offered
11.15.3 eMedyun Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 eMedyun Main Business Overview
11.15.5 eMedyun Latest Developments
11.16 Bioknow
11.16.1 Bioknow Company Information
11.16.2 Bioknow Drug Safety and Pharmacovigilance (PV) Software Product Offered
11.16.3 Bioknow Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Bioknow Main Business Overview
11.16.5 Bioknow Latest Developments
11.17 Singedi Health
11.17.1 Singedi Health Company Information
11.17.2 Singedi Health Drug Safety and Pharmacovigilance (PV) Software Product Offered
11.17.3 Singedi Health Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 Singedi Health Main Business Overview
11.17.5 Singedi Health Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Drug Safety and Pharmacovigilance (PV) Software Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Drug Safety and Pharmacovigilance (PV) Software Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of On-Premises
Table 4. Major Players of Cloud-Based
Table 5. Drug Safety and Pharmacovigilance (PV) Software Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Drug Safety and Pharmacovigilance (PV) Software Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Type (2021-2026)
Table 8. Major Players of Pre-market
Table 9. Major Players of Post-market
Table 10. Drug Safety and Pharmacovigilance (PV) Software Market Size CAGR by Data Range (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global Drug Safety and Pharmacovigilance (PV) Software Market Size by Data Range (2021-2026) & ($ millions)
Table 12. Global Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Data Range (2021-2026)
Table 13. Major Players of Security Database
Table 14. Major Players of Signal Detection
Table 15. Major Players of Compliance Report
Table 16. Major Players of Other
Table 17. Drug Safety and Pharmacovigilance (PV) Software Market Size CAGR by Functional Modules (2021 VS 2025 VS 2032) & ($ millions)
Table 18. Global Drug Safety and Pharmacovigilance (PV) Software Market Size by Functional Modules (2021-2026) & ($ millions)
Table 19. Global Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Functional Modules (2021-2026)
Table 20. Drug Safety and Pharmacovigilance (PV) Software Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 21. Global Drug Safety and Pharmacovigilance (PV) Software Market Size by Application (2021-2026) & ($ millions)
Table 22. Global Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Application (2021-2026)
Table 23. Global Drug Safety and Pharmacovigilance (PV) Software Revenue by Player (2021-2026) & ($ millions)
Table 24. Global Drug Safety and Pharmacovigilance (PV) Software Revenue Market Share by Player (2021-2026)
Table 25. Drug Safety and Pharmacovigilance (PV) Software Key Players Head office and Products Offered
Table 26. Drug Safety and Pharmacovigilance (PV) Software Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 27. New Products and Potential Entrants
Table 28. Mergers & Acquisitions, Expansion
Table 29. Global Drug Safety and Pharmacovigilance (PV) Software Market Size by Region (2021-2026) & ($ millions)
Table 30. Global Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Region (2021-2026)
Table 31. Global Drug Safety and Pharmacovigilance (PV) Software Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Drug Safety and Pharmacovigilance (PV) Software Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Drug Safety and Pharmacovigilance (PV) Software Market Size by Country (2021-2026) & ($ millions)
Table 34. Americas Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Country (2021-2026)
Table 35. Americas Drug Safety and Pharmacovigilance (PV) Software Market Size by Type (2021-2026) & ($ millions)
Table 36. Americas Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Type (2021-2026)
Table 37. Americas Drug Safety and Pharmacovigilance (PV) Software Market Size by Application (2021-2026) & ($ millions)
Table 38. Americas Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Application (2021-2026)
Table 39. APAC Drug Safety and Pharmacovigilance (PV) Software Market Size by Region (2021-2026) & ($ millions)
Table 40. APAC Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Region (2021-2026)
Table 41. APAC Drug Safety and Pharmacovigilance (PV) Software Market Size by Type (2021-2026) & ($ millions)
Table 42. APAC Drug Safety and Pharmacovigilance (PV) Software Market Size by Application (2021-2026) & ($ millions)
Table 43. Europe Drug Safety and Pharmacovigilance (PV) Software Market Size by Country (2021-2026) & ($ millions)
Table 44. Europe Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Country (2021-2026)
Table 45. Europe Drug Safety and Pharmacovigilance (PV) Software Market Size by Type (2021-2026) & ($ millions)
Table 46. Europe Drug Safety and Pharmacovigilance (PV) Software Market Size by Application (2021-2026) & ($ millions)
Table 47. Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Size by Region (2021-2026) & ($ millions)
Table 48. Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Size by Type (2021-2026) & ($ millions)
Table 49. Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Size by Application (2021-2026) & ($ millions)
Table 50. Key Market Drivers & Growth Opportunities of Drug Safety and Pharmacovigilance (PV) Software
Table 51. Key Market Challenges & Risks of Drug Safety and Pharmacovigilance (PV) Software
Table 52. Key Industry Trends of Drug Safety and Pharmacovigilance (PV) Software
Table 53. Global Drug Safety and Pharmacovigilance (PV) Software Market Size Forecast by Region (2027-2032) & ($ millions)
Table 54. Global Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share Forecast by Region (2027-2032)
Table 55. Global Drug Safety and Pharmacovigilance (PV) Software Market Size Forecast by Type (2027-2032) & ($ millions)
Table 56. Global Drug Safety and Pharmacovigilance (PV) Software Market Size Forecast by Application (2027-2032) & ($ millions)
Table 57. Oracle Details, Company Type, Drug Safety and Pharmacovigilance (PV) Software Area Served and Its Competitors
Table 58. Oracle Drug Safety and Pharmacovigilance (PV) Software Product Offered
Table 59. Oracle Drug Safety and Pharmacovigilance (PV) Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 60. Oracle Main Business
Table 61. Oracle Latest Developments
Table 62. Veeva Systems Details, Company Type, Drug Safety and Pharmacovigilance (PV) Software Area Served and Its Competitors
Table 63. Veeva Systems Drug Safety and Pharmacovigilance (PV) Software Product Offered
Table 64. Veeva Systems Drug Safety and Pharmacovigilance (PV) Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 65. Veeva Systems Main Business
Table 66. Veeva Systems Latest Developments
Table 67. ArisGlobal Details, Company Type, Drug Safety and Pharmacovigilance (PV) Software Area Served and Its Competitors
Table 68. ArisGlobal Drug Safety and Pharmacovigilance (PV) Software Product Offered
Table 69. ArisGlobal Drug Safety and Pharmacovigilance (PV) Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 70. ArisGlobal Main Business
Table 71. ArisGlobal Latest Developments
Table 72. IQVIA Details, Company Type, Drug Safety and Pharmacovigilance (PV) Software Area Served and Its Competitors
Table 73. IQVIA Drug Safety and Pharmacovigilance (PV) Software Product Offered
Table 74. IQVIA Drug Safety and Pharmacovigilance (PV) Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 75. IQVIA Main Business
Table 76. IQVIA Latest Developments
Table 77. EXTEDO Details, Company Type, Drug Safety and Pharmacovigilance (PV) Software Area Served and Its Competitors
Table 78. EXTEDO Drug Safety and Pharmacovigilance (PV) Software Product Offered
Table 79. EXTEDO Drug Safety and Pharmacovigilance (PV) Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 80. EXTEDO Main Business
Table 81. EXTEDO Latest Developments
Table 82. RxLogix Details, Company Type, Drug Safety and Pharmacovigilance (PV) Software Area Served and Its Competitors
Table 83. RxLogix Drug Safety and Pharmacovigilance (PV) Software Product Offered
Table 84. RxLogix Drug Safety and Pharmacovigilance (PV) Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 85. RxLogix Main Business
Table 86. RxLogix Latest Developments
Table 87. Ennov Details, Company Type, Drug Safety and Pharmacovigilance (PV) Software Area Served and Its Competitors
Table 88. Ennov Drug Safety and Pharmacovigilance (PV) Software Product Offered
Table 89. Ennov Drug Safety and Pharmacovigilance (PV) Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 90. Ennov Main Business
Table 91. Ennov Latest Developments
Table 92. Uppsala Monitoring Centre Details, Company Type, Drug Safety and Pharmacovigilance (PV) Software Area Served and Its Competitors
Table 93. Uppsala Monitoring Centre Drug Safety and Pharmacovigilance (PV) Software Product Offered
Table 94. Uppsala Monitoring Centre Drug Safety and Pharmacovigilance (PV) Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 95. Uppsala Monitoring Centre Main Business
Table 96. Uppsala Monitoring Centre Latest Developments
Table 97. Medidata Details, Company Type, Drug Safety and Pharmacovigilance (PV) Software Area Served and Its Competitors
Table 98. Medidata Drug Safety and Pharmacovigilance (PV) Software Product Offered
Table 99. Medidata Drug Safety and Pharmacovigilance (PV) Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 100. Medidata Main Business
Table 101. Medidata Latest Developments
Table 102. Clarivate Details, Company Type, Drug Safety and Pharmacovigilance (PV) Software Area Served and Its Competitors
Table 103. Clarivate Drug Safety and Pharmacovigilance (PV) Software Product Offered
Table 104. Clarivate Drug Safety and Pharmacovigilance (PV) Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 105. Clarivate Main Business
Table 106. Clarivate Latest Developments
Table 107. AB Cube Details, Company Type, Drug Safety and Pharmacovigilance (PV) Software Area Served and Its Competitors
Table 108. AB Cube Drug Safety and Pharmacovigilance (PV) Software Product Offered
Table 109. AB Cube Drug Safety and Pharmacovigilance (PV) Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 110. AB Cube Main Business
Table 111. AB Cube Latest Developments
Table 112. Cloudbyz Details, Company Type, Drug Safety and Pharmacovigilance (PV) Software Area Served and Its Competitors
Table 113. Cloudbyz Drug Safety and Pharmacovigilance (PV) Software Product Offered
Table 114. Cloudbyz Drug Safety and Pharmacovigilance (PV) Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 115. Cloudbyz Main Business
Table 116. Cloudbyz Latest Developments
Table 117. Cognizant Technology Details, Company Type, Drug Safety and Pharmacovigilance (PV) Software Area Served and Its Competitors
Table 118. Cognizant Technology Drug Safety and Pharmacovigilance (PV) Software Product Offered
Table 119. Cognizant Technology Drug Safety and Pharmacovigilance (PV) Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 120. Cognizant Technology Main Business
Table 121. Cognizant Technology Latest Developments
Table 122. Taimei Technology Details, Company Type, Drug Safety and Pharmacovigilance (PV) Software Area Served and Its Competitors
Table 123. Taimei Technology Drug Safety and Pharmacovigilance (PV) Software Product Offered
Table 124. Taimei Technology Drug Safety and Pharmacovigilance (PV) Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 125. Taimei Technology Main Business
Table 126. Taimei Technology Latest Developments
Table 127. eMedyun Details, Company Type, Drug Safety and Pharmacovigilance (PV) Software Area Served and Its Competitors
Table 128. eMedyun Drug Safety and Pharmacovigilance (PV) Software Product Offered
Table 129. eMedyun Drug Safety and Pharmacovigilance (PV) Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 130. eMedyun Main Business
Table 131. eMedyun Latest Developments
Table 132. Bioknow Details, Company Type, Drug Safety and Pharmacovigilance (PV) Software Area Served and Its Competitors
Table 133. Bioknow Drug Safety and Pharmacovigilance (PV) Software Product Offered
Table 134. Bioknow Drug Safety and Pharmacovigilance (PV) Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 135. Bioknow Main Business
Table 136. Bioknow Latest Developments
Table 137. Singedi Health Details, Company Type, Drug Safety and Pharmacovigilance (PV) Software Area Served and Its Competitors
Table 138. Singedi Health Drug Safety and Pharmacovigilance (PV) Software Product Offered
Table 139. Singedi Health Drug Safety and Pharmacovigilance (PV) Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 140. Singedi Health Main Business
Table 141. Singedi Health Latest Developments
Table 1. Drug Safety and Pharmacovigilance (PV) Software Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Drug Safety and Pharmacovigilance (PV) Software Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of On-Premises
Table 4. Major Players of Cloud-Based
Table 5. Drug Safety and Pharmacovigilance (PV) Software Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Drug Safety and Pharmacovigilance (PV) Software Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Type (2021-2026)
Table 8. Major Players of Pre-market
Table 9. Major Players of Post-market
Table 10. Drug Safety and Pharmacovigilance (PV) Software Market Size CAGR by Data Range (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global Drug Safety and Pharmacovigilance (PV) Software Market Size by Data Range (2021-2026) & ($ millions)
Table 12. Global Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Data Range (2021-2026)
Table 13. Major Players of Security Database
Table 14. Major Players of Signal Detection
Table 15. Major Players of Compliance Report
Table 16. Major Players of Other
Table 17. Drug Safety and Pharmacovigilance (PV) Software Market Size CAGR by Functional Modules (2021 VS 2025 VS 2032) & ($ millions)
Table 18. Global Drug Safety and Pharmacovigilance (PV) Software Market Size by Functional Modules (2021-2026) & ($ millions)
Table 19. Global Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Functional Modules (2021-2026)
Table 20. Drug Safety and Pharmacovigilance (PV) Software Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 21. Global Drug Safety and Pharmacovigilance (PV) Software Market Size by Application (2021-2026) & ($ millions)
Table 22. Global Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Application (2021-2026)
Table 23. Global Drug Safety and Pharmacovigilance (PV) Software Revenue by Player (2021-2026) & ($ millions)
Table 24. Global Drug Safety and Pharmacovigilance (PV) Software Revenue Market Share by Player (2021-2026)
Table 25. Drug Safety and Pharmacovigilance (PV) Software Key Players Head office and Products Offered
Table 26. Drug Safety and Pharmacovigilance (PV) Software Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 27. New Products and Potential Entrants
Table 28. Mergers & Acquisitions, Expansion
Table 29. Global Drug Safety and Pharmacovigilance (PV) Software Market Size by Region (2021-2026) & ($ millions)
Table 30. Global Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Region (2021-2026)
Table 31. Global Drug Safety and Pharmacovigilance (PV) Software Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Drug Safety and Pharmacovigilance (PV) Software Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Drug Safety and Pharmacovigilance (PV) Software Market Size by Country (2021-2026) & ($ millions)
Table 34. Americas Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Country (2021-2026)
Table 35. Americas Drug Safety and Pharmacovigilance (PV) Software Market Size by Type (2021-2026) & ($ millions)
Table 36. Americas Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Type (2021-2026)
Table 37. Americas Drug Safety and Pharmacovigilance (PV) Software Market Size by Application (2021-2026) & ($ millions)
Table 38. Americas Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Application (2021-2026)
Table 39. APAC Drug Safety and Pharmacovigilance (PV) Software Market Size by Region (2021-2026) & ($ millions)
Table 40. APAC Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Region (2021-2026)
Table 41. APAC Drug Safety and Pharmacovigilance (PV) Software Market Size by Type (2021-2026) & ($ millions)
Table 42. APAC Drug Safety and Pharmacovigilance (PV) Software Market Size by Application (2021-2026) & ($ millions)
Table 43. Europe Drug Safety and Pharmacovigilance (PV) Software Market Size by Country (2021-2026) & ($ millions)
Table 44. Europe Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Country (2021-2026)
Table 45. Europe Drug Safety and Pharmacovigilance (PV) Software Market Size by Type (2021-2026) & ($ millions)
Table 46. Europe Drug Safety and Pharmacovigilance (PV) Software Market Size by Application (2021-2026) & ($ millions)
Table 47. Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Size by Region (2021-2026) & ($ millions)
Table 48. Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Size by Type (2021-2026) & ($ millions)
Table 49. Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Size by Application (2021-2026) & ($ millions)
Table 50. Key Market Drivers & Growth Opportunities of Drug Safety and Pharmacovigilance (PV) Software
Table 51. Key Market Challenges & Risks of Drug Safety and Pharmacovigilance (PV) Software
Table 52. Key Industry Trends of Drug Safety and Pharmacovigilance (PV) Software
Table 53. Global Drug Safety and Pharmacovigilance (PV) Software Market Size Forecast by Region (2027-2032) & ($ millions)
Table 54. Global Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share Forecast by Region (2027-2032)
Table 55. Global Drug Safety and Pharmacovigilance (PV) Software Market Size Forecast by Type (2027-2032) & ($ millions)
Table 56. Global Drug Safety and Pharmacovigilance (PV) Software Market Size Forecast by Application (2027-2032) & ($ millions)
Table 57. Oracle Details, Company Type, Drug Safety and Pharmacovigilance (PV) Software Area Served and Its Competitors
Table 58. Oracle Drug Safety and Pharmacovigilance (PV) Software Product Offered
Table 59. Oracle Drug Safety and Pharmacovigilance (PV) Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 60. Oracle Main Business
Table 61. Oracle Latest Developments
Table 62. Veeva Systems Details, Company Type, Drug Safety and Pharmacovigilance (PV) Software Area Served and Its Competitors
Table 63. Veeva Systems Drug Safety and Pharmacovigilance (PV) Software Product Offered
Table 64. Veeva Systems Drug Safety and Pharmacovigilance (PV) Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 65. Veeva Systems Main Business
Table 66. Veeva Systems Latest Developments
Table 67. ArisGlobal Details, Company Type, Drug Safety and Pharmacovigilance (PV) Software Area Served and Its Competitors
Table 68. ArisGlobal Drug Safety and Pharmacovigilance (PV) Software Product Offered
Table 69. ArisGlobal Drug Safety and Pharmacovigilance (PV) Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 70. ArisGlobal Main Business
Table 71. ArisGlobal Latest Developments
Table 72. IQVIA Details, Company Type, Drug Safety and Pharmacovigilance (PV) Software Area Served and Its Competitors
Table 73. IQVIA Drug Safety and Pharmacovigilance (PV) Software Product Offered
Table 74. IQVIA Drug Safety and Pharmacovigilance (PV) Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 75. IQVIA Main Business
Table 76. IQVIA Latest Developments
Table 77. EXTEDO Details, Company Type, Drug Safety and Pharmacovigilance (PV) Software Area Served and Its Competitors
Table 78. EXTEDO Drug Safety and Pharmacovigilance (PV) Software Product Offered
Table 79. EXTEDO Drug Safety and Pharmacovigilance (PV) Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 80. EXTEDO Main Business
Table 81. EXTEDO Latest Developments
Table 82. RxLogix Details, Company Type, Drug Safety and Pharmacovigilance (PV) Software Area Served and Its Competitors
Table 83. RxLogix Drug Safety and Pharmacovigilance (PV) Software Product Offered
Table 84. RxLogix Drug Safety and Pharmacovigilance (PV) Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 85. RxLogix Main Business
Table 86. RxLogix Latest Developments
Table 87. Ennov Details, Company Type, Drug Safety and Pharmacovigilance (PV) Software Area Served and Its Competitors
Table 88. Ennov Drug Safety and Pharmacovigilance (PV) Software Product Offered
Table 89. Ennov Drug Safety and Pharmacovigilance (PV) Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 90. Ennov Main Business
Table 91. Ennov Latest Developments
Table 92. Uppsala Monitoring Centre Details, Company Type, Drug Safety and Pharmacovigilance (PV) Software Area Served and Its Competitors
Table 93. Uppsala Monitoring Centre Drug Safety and Pharmacovigilance (PV) Software Product Offered
Table 94. Uppsala Monitoring Centre Drug Safety and Pharmacovigilance (PV) Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 95. Uppsala Monitoring Centre Main Business
Table 96. Uppsala Monitoring Centre Latest Developments
Table 97. Medidata Details, Company Type, Drug Safety and Pharmacovigilance (PV) Software Area Served and Its Competitors
Table 98. Medidata Drug Safety and Pharmacovigilance (PV) Software Product Offered
Table 99. Medidata Drug Safety and Pharmacovigilance (PV) Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 100. Medidata Main Business
Table 101. Medidata Latest Developments
Table 102. Clarivate Details, Company Type, Drug Safety and Pharmacovigilance (PV) Software Area Served and Its Competitors
Table 103. Clarivate Drug Safety and Pharmacovigilance (PV) Software Product Offered
Table 104. Clarivate Drug Safety and Pharmacovigilance (PV) Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 105. Clarivate Main Business
Table 106. Clarivate Latest Developments
Table 107. AB Cube Details, Company Type, Drug Safety and Pharmacovigilance (PV) Software Area Served and Its Competitors
Table 108. AB Cube Drug Safety and Pharmacovigilance (PV) Software Product Offered
Table 109. AB Cube Drug Safety and Pharmacovigilance (PV) Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 110. AB Cube Main Business
Table 111. AB Cube Latest Developments
Table 112. Cloudbyz Details, Company Type, Drug Safety and Pharmacovigilance (PV) Software Area Served and Its Competitors
Table 113. Cloudbyz Drug Safety and Pharmacovigilance (PV) Software Product Offered
Table 114. Cloudbyz Drug Safety and Pharmacovigilance (PV) Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 115. Cloudbyz Main Business
Table 116. Cloudbyz Latest Developments
Table 117. Cognizant Technology Details, Company Type, Drug Safety and Pharmacovigilance (PV) Software Area Served and Its Competitors
Table 118. Cognizant Technology Drug Safety and Pharmacovigilance (PV) Software Product Offered
Table 119. Cognizant Technology Drug Safety and Pharmacovigilance (PV) Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 120. Cognizant Technology Main Business
Table 121. Cognizant Technology Latest Developments
Table 122. Taimei Technology Details, Company Type, Drug Safety and Pharmacovigilance (PV) Software Area Served and Its Competitors
Table 123. Taimei Technology Drug Safety and Pharmacovigilance (PV) Software Product Offered
Table 124. Taimei Technology Drug Safety and Pharmacovigilance (PV) Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 125. Taimei Technology Main Business
Table 126. Taimei Technology Latest Developments
Table 127. eMedyun Details, Company Type, Drug Safety and Pharmacovigilance (PV) Software Area Served and Its Competitors
Table 128. eMedyun Drug Safety and Pharmacovigilance (PV) Software Product Offered
Table 129. eMedyun Drug Safety and Pharmacovigilance (PV) Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 130. eMedyun Main Business
Table 131. eMedyun Latest Developments
Table 132. Bioknow Details, Company Type, Drug Safety and Pharmacovigilance (PV) Software Area Served and Its Competitors
Table 133. Bioknow Drug Safety and Pharmacovigilance (PV) Software Product Offered
Table 134. Bioknow Drug Safety and Pharmacovigilance (PV) Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 135. Bioknow Main Business
Table 136. Bioknow Latest Developments
Table 137. Singedi Health Details, Company Type, Drug Safety and Pharmacovigilance (PV) Software Area Served and Its Competitors
Table 138. Singedi Health Drug Safety and Pharmacovigilance (PV) Software Product Offered
Table 139. Singedi Health Drug Safety and Pharmacovigilance (PV) Software Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 140. Singedi Health Main Business
Table 141. Singedi Health Latest Developments
LIST OF FIGURES
Figure 1. Drug Safety and Pharmacovigilance (PV) Software Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Drug Safety and Pharmacovigilance (PV) Software Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Drug Safety and Pharmacovigilance (PV) Software Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Drug Safety and Pharmacovigilance (PV) Software Sales Market Share by Country/Region (2025)
Figure 8. Drug Safety and Pharmacovigilance (PV) Software Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Type in 2025
Figure 10. Global Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Data Range in 2025
Figure 11. Global Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Functional Modules in 2025
Figure 12. Drug Safety and Pharmacovigilance (PV) Software in Pharma and Biotech Companies
Figure 13. Global Drug Safety and Pharmacovigilance (PV) Software Market: Pharma and Biotech Companies (2021-2026) & ($ millions)
Figure 14. Drug Safety and Pharmacovigilance (PV) Software in Contract Research Organizations (CROs)
Figure 15. Global Drug Safety and Pharmacovigilance (PV) Software Market: Contract Research Organizations (CROs) (2021-2026) & ($ millions)
Figure 16. Drug Safety and Pharmacovigilance (PV) Software in Business Process Outsourcing (BPO) Firms
Figure 17. Global Drug Safety and Pharmacovigilance (PV) Software Market: Business Process Outsourcing (BPO) Firms (2021-2026) & ($ millions)
Figure 18. Drug Safety and Pharmacovigilance (PV) Software in Other
Figure 19. Global Drug Safety and Pharmacovigilance (PV) Software Market: Other (2021-2026) & ($ millions)
Figure 20. Global Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Application in 2025
Figure 21. Global Drug Safety and Pharmacovigilance (PV) Software Revenue Market Share by Player in 2025
Figure 22. Global Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Region (2021-2026)
Figure 23. Americas Drug Safety and Pharmacovigilance (PV) Software Market Size 2021-2026 ($ millions)
Figure 24. APAC Drug Safety and Pharmacovigilance (PV) Software Market Size 2021-2026 ($ millions)
Figure 25. Europe Drug Safety and Pharmacovigilance (PV) Software Market Size 2021-2026 ($ millions)
Figure 26. Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Size 2021-2026 ($ millions)
Figure 27. Americas Drug Safety and Pharmacovigilance (PV) Software Value Market Share by Country in 2025
Figure 28. United States Drug Safety and Pharmacovigilance (PV) Software Market Size Growth 2021-2026 ($ millions)
Figure 29. Canada Drug Safety and Pharmacovigilance (PV) Software Market Size Growth 2021-2026 ($ millions)
Figure 30. Mexico Drug Safety and Pharmacovigilance (PV) Software Market Size Growth 2021-2026 ($ millions)
Figure 31. Brazil Drug Safety and Pharmacovigilance (PV) Software Market Size Growth 2021-2026 ($ millions)
Figure 32. APAC Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Region in 2025
Figure 33. APAC Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Type (2021-2026)
Figure 34. APAC Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Application (2021-2026)
Figure 35. China Drug Safety and Pharmacovigilance (PV) Software Market Size Growth 2021-2026 ($ millions)
Figure 36. Japan Drug Safety and Pharmacovigilance (PV) Software Market Size Growth 2021-2026 ($ millions)
Figure 37. South Korea Drug Safety and Pharmacovigilance (PV) Software Market Size Growth 2021-2026 ($ millions)
Figure 38. Southeast Asia Drug Safety and Pharmacovigilance (PV) Software Market Size Growth 2021-2026 ($ millions)
Figure 39. India Drug Safety and Pharmacovigilance (PV) Software Market Size Growth 2021-2026 ($ millions)
Figure 40. Australia Drug Safety and Pharmacovigilance (PV) Software Market Size Growth 2021-2026 ($ millions)
Figure 41. Europe Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Country in 2025
Figure 42. Europe Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Type (2021-2026)
Figure 43. Europe Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Application (2021-2026)
Figure 44. Germany Drug Safety and Pharmacovigilance (PV) Software Market Size Growth 2021-2026 ($ millions)
Figure 45. France Drug Safety and Pharmacovigilance (PV) Software Market Size Growth 2021-2026 ($ millions)
Figure 46. UK Drug Safety and Pharmacovigilance (PV) Software Market Size Growth 2021-2026 ($ millions)
Figure 47. Italy Drug Safety and Pharmacovigilance (PV) Software Market Size Growth 2021-2026 ($ millions)
Figure 48. Russia Drug Safety and Pharmacovigilance (PV) Software Market Size Growth 2021-2026 ($ millions)
Figure 49. Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Region (2021-2026)
Figure 50. Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Type (2021-2026)
Figure 51. Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Application (2021-2026)
Figure 52. Egypt Drug Safety and Pharmacovigilance (PV) Software Market Size Growth 2021-2026 ($ millions)
Figure 53. South Africa Drug Safety and Pharmacovigilance (PV) Software Market Size Growth 2021-2026 ($ millions)
Figure 54. Israel Drug Safety and Pharmacovigilance (PV) Software Market Size Growth 2021-2026 ($ millions)
Figure 55. Turkey Drug Safety and Pharmacovigilance (PV) Software Market Size Growth 2021-2026 ($ millions)
Figure 56. GCC Countries Drug Safety and Pharmacovigilance (PV) Software Market Size Growth 2021-2026 ($ millions)
Figure 57. Americas Drug Safety and Pharmacovigilance (PV) Software Market Size 2027-2032 ($ millions)
Figure 58. APAC Drug Safety and Pharmacovigilance (PV) Software Market Size 2027-2032 ($ millions)
Figure 59. Europe Drug Safety and Pharmacovigilance (PV) Software Market Size 2027-2032 ($ millions)
Figure 60. Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Size 2027-2032 ($ millions)
Figure 61. United States Drug Safety and Pharmacovigilance (PV) Software Market Size 2027-2032 ($ millions)
Figure 62. Canada Drug Safety and Pharmacovigilance (PV) Software Market Size 2027-2032 ($ millions)
Figure 63. Mexico Drug Safety and Pharmacovigilance (PV) Software Market Size 2027-2032 ($ millions)
Figure 64. Brazil Drug Safety and Pharmacovigilance (PV) Software Market Size 2027-2032 ($ millions)
Figure 65. China Drug Safety and Pharmacovigilance (PV) Software Market Size 2027-2032 ($ millions)
Figure 66. Japan Drug Safety and Pharmacovigilance (PV) Software Market Size 2027-2032 ($ millions)
Figure 67. Korea Drug Safety and Pharmacovigilance (PV) Software Market Size 2027-2032 ($ millions)
Figure 68. Southeast Asia Drug Safety and Pharmacovigilance (PV) Software Market Size 2027-2032 ($ millions)
Figure 69. India Drug Safety and Pharmacovigilance (PV) Software Market Size 2027-2032 ($ millions)
Figure 70. Australia Drug Safety and Pharmacovigilance (PV) Software Market Size 2027-2032 ($ millions)
Figure 71. Germany Drug Safety and Pharmacovigilance (PV) Software Market Size 2027-2032 ($ millions)
Figure 72. France Drug Safety and Pharmacovigilance (PV) Software Market Size 2027-2032 ($ millions)
Figure 73. UK Drug Safety and Pharmacovigilance (PV) Software Market Size 2027-2032 ($ millions)
Figure 74. Italy Drug Safety and Pharmacovigilance (PV) Software Market Size 2027-2032 ($ millions)
Figure 75. Russia Drug Safety and Pharmacovigilance (PV) Software Market Size 2027-2032 ($ millions)
Figure 76. Egypt Drug Safety and Pharmacovigilance (PV) Software Market Size 2027-2032 ($ millions)
Figure 77. South Africa Drug Safety and Pharmacovigilance (PV) Software Market Size 2027-2032 ($ millions)
Figure 78. Israel Drug Safety and Pharmacovigilance (PV) Software Market Size 2027-2032 ($ millions)
Figure 79. Turkey Drug Safety and Pharmacovigilance (PV) Software Market Size 2027-2032 ($ millions)
Figure 80. Global Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share Forecast by Type (2027-2032)
Figure 81. Global Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share Forecast by Application (2027-2032)
Figure 82. GCC Countries Drug Safety and Pharmacovigilance (PV) Software Market Size 2027-2032 ($ millions)
Figure 1. Drug Safety and Pharmacovigilance (PV) Software Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Drug Safety and Pharmacovigilance (PV) Software Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Drug Safety and Pharmacovigilance (PV) Software Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Drug Safety and Pharmacovigilance (PV) Software Sales Market Share by Country/Region (2025)
Figure 8. Drug Safety and Pharmacovigilance (PV) Software Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Type in 2025
Figure 10. Global Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Data Range in 2025
Figure 11. Global Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Functional Modules in 2025
Figure 12. Drug Safety and Pharmacovigilance (PV) Software in Pharma and Biotech Companies
Figure 13. Global Drug Safety and Pharmacovigilance (PV) Software Market: Pharma and Biotech Companies (2021-2026) & ($ millions)
Figure 14. Drug Safety and Pharmacovigilance (PV) Software in Contract Research Organizations (CROs)
Figure 15. Global Drug Safety and Pharmacovigilance (PV) Software Market: Contract Research Organizations (CROs) (2021-2026) & ($ millions)
Figure 16. Drug Safety and Pharmacovigilance (PV) Software in Business Process Outsourcing (BPO) Firms
Figure 17. Global Drug Safety and Pharmacovigilance (PV) Software Market: Business Process Outsourcing (BPO) Firms (2021-2026) & ($ millions)
Figure 18. Drug Safety and Pharmacovigilance (PV) Software in Other
Figure 19. Global Drug Safety and Pharmacovigilance (PV) Software Market: Other (2021-2026) & ($ millions)
Figure 20. Global Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Application in 2025
Figure 21. Global Drug Safety and Pharmacovigilance (PV) Software Revenue Market Share by Player in 2025
Figure 22. Global Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Region (2021-2026)
Figure 23. Americas Drug Safety and Pharmacovigilance (PV) Software Market Size 2021-2026 ($ millions)
Figure 24. APAC Drug Safety and Pharmacovigilance (PV) Software Market Size 2021-2026 ($ millions)
Figure 25. Europe Drug Safety and Pharmacovigilance (PV) Software Market Size 2021-2026 ($ millions)
Figure 26. Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Size 2021-2026 ($ millions)
Figure 27. Americas Drug Safety and Pharmacovigilance (PV) Software Value Market Share by Country in 2025
Figure 28. United States Drug Safety and Pharmacovigilance (PV) Software Market Size Growth 2021-2026 ($ millions)
Figure 29. Canada Drug Safety and Pharmacovigilance (PV) Software Market Size Growth 2021-2026 ($ millions)
Figure 30. Mexico Drug Safety and Pharmacovigilance (PV) Software Market Size Growth 2021-2026 ($ millions)
Figure 31. Brazil Drug Safety and Pharmacovigilance (PV) Software Market Size Growth 2021-2026 ($ millions)
Figure 32. APAC Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Region in 2025
Figure 33. APAC Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Type (2021-2026)
Figure 34. APAC Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Application (2021-2026)
Figure 35. China Drug Safety and Pharmacovigilance (PV) Software Market Size Growth 2021-2026 ($ millions)
Figure 36. Japan Drug Safety and Pharmacovigilance (PV) Software Market Size Growth 2021-2026 ($ millions)
Figure 37. South Korea Drug Safety and Pharmacovigilance (PV) Software Market Size Growth 2021-2026 ($ millions)
Figure 38. Southeast Asia Drug Safety and Pharmacovigilance (PV) Software Market Size Growth 2021-2026 ($ millions)
Figure 39. India Drug Safety and Pharmacovigilance (PV) Software Market Size Growth 2021-2026 ($ millions)
Figure 40. Australia Drug Safety and Pharmacovigilance (PV) Software Market Size Growth 2021-2026 ($ millions)
Figure 41. Europe Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Country in 2025
Figure 42. Europe Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Type (2021-2026)
Figure 43. Europe Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Application (2021-2026)
Figure 44. Germany Drug Safety and Pharmacovigilance (PV) Software Market Size Growth 2021-2026 ($ millions)
Figure 45. France Drug Safety and Pharmacovigilance (PV) Software Market Size Growth 2021-2026 ($ millions)
Figure 46. UK Drug Safety and Pharmacovigilance (PV) Software Market Size Growth 2021-2026 ($ millions)
Figure 47. Italy Drug Safety and Pharmacovigilance (PV) Software Market Size Growth 2021-2026 ($ millions)
Figure 48. Russia Drug Safety and Pharmacovigilance (PV) Software Market Size Growth 2021-2026 ($ millions)
Figure 49. Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Region (2021-2026)
Figure 50. Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Type (2021-2026)
Figure 51. Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Application (2021-2026)
Figure 52. Egypt Drug Safety and Pharmacovigilance (PV) Software Market Size Growth 2021-2026 ($ millions)
Figure 53. South Africa Drug Safety and Pharmacovigilance (PV) Software Market Size Growth 2021-2026 ($ millions)
Figure 54. Israel Drug Safety and Pharmacovigilance (PV) Software Market Size Growth 2021-2026 ($ millions)
Figure 55. Turkey Drug Safety and Pharmacovigilance (PV) Software Market Size Growth 2021-2026 ($ millions)
Figure 56. GCC Countries Drug Safety and Pharmacovigilance (PV) Software Market Size Growth 2021-2026 ($ millions)
Figure 57. Americas Drug Safety and Pharmacovigilance (PV) Software Market Size 2027-2032 ($ millions)
Figure 58. APAC Drug Safety and Pharmacovigilance (PV) Software Market Size 2027-2032 ($ millions)
Figure 59. Europe Drug Safety and Pharmacovigilance (PV) Software Market Size 2027-2032 ($ millions)
Figure 60. Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Size 2027-2032 ($ millions)
Figure 61. United States Drug Safety and Pharmacovigilance (PV) Software Market Size 2027-2032 ($ millions)
Figure 62. Canada Drug Safety and Pharmacovigilance (PV) Software Market Size 2027-2032 ($ millions)
Figure 63. Mexico Drug Safety and Pharmacovigilance (PV) Software Market Size 2027-2032 ($ millions)
Figure 64. Brazil Drug Safety and Pharmacovigilance (PV) Software Market Size 2027-2032 ($ millions)
Figure 65. China Drug Safety and Pharmacovigilance (PV) Software Market Size 2027-2032 ($ millions)
Figure 66. Japan Drug Safety and Pharmacovigilance (PV) Software Market Size 2027-2032 ($ millions)
Figure 67. Korea Drug Safety and Pharmacovigilance (PV) Software Market Size 2027-2032 ($ millions)
Figure 68. Southeast Asia Drug Safety and Pharmacovigilance (PV) Software Market Size 2027-2032 ($ millions)
Figure 69. India Drug Safety and Pharmacovigilance (PV) Software Market Size 2027-2032 ($ millions)
Figure 70. Australia Drug Safety and Pharmacovigilance (PV) Software Market Size 2027-2032 ($ millions)
Figure 71. Germany Drug Safety and Pharmacovigilance (PV) Software Market Size 2027-2032 ($ millions)
Figure 72. France Drug Safety and Pharmacovigilance (PV) Software Market Size 2027-2032 ($ millions)
Figure 73. UK Drug Safety and Pharmacovigilance (PV) Software Market Size 2027-2032 ($ millions)
Figure 74. Italy Drug Safety and Pharmacovigilance (PV) Software Market Size 2027-2032 ($ millions)
Figure 75. Russia Drug Safety and Pharmacovigilance (PV) Software Market Size 2027-2032 ($ millions)
Figure 76. Egypt Drug Safety and Pharmacovigilance (PV) Software Market Size 2027-2032 ($ millions)
Figure 77. South Africa Drug Safety and Pharmacovigilance (PV) Software Market Size 2027-2032 ($ millions)
Figure 78. Israel Drug Safety and Pharmacovigilance (PV) Software Market Size 2027-2032 ($ millions)
Figure 79. Turkey Drug Safety and Pharmacovigilance (PV) Software Market Size 2027-2032 ($ millions)
Figure 80. Global Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share Forecast by Type (2027-2032)
Figure 81. Global Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share Forecast by Application (2027-2032)
Figure 82. GCC Countries Drug Safety and Pharmacovigilance (PV) Software Market Size 2027-2032 ($ millions)
